News

Richard Bedlack, MD, PhD contributed to an original paper in Muscle & Nerve that shared

Birgit Frauscher, MD was senior author of an article in 

Drs. Cathleen Colón-Emeric, Loretta Que and Heather Whitson were selected as a members of the 2024-2025 class of fellows for the 

Dr. Peters provides clarity on a new analysis of the INDIGO study highlighting treatment benefits of vorasidenib in patients with IDH mutant grade 2 gliomas.

Andy Liu, MD, Kim Johnson, MD, and Burt Scott, MD, PhD were recipients of this year's Michelle P. Winn Inclusive Excellence Award.

Dr. Collins comments on how the climate crisis could impact migraine frequency and intensity.

Dr. Bedlack comments on the use of Qalsody and its impact on ALS patients with the SOD1 gene.

Read about Charalambos "Bobby" Charalambous, PhD and his role and research mission as a Medical Instructor in the Department of Neurology.

The following is a proclamation by Governor Cooper stating May 2024 is to be observed as Huntington's Disease Awareness Month.

Dr. Bedlack provides perspective on the results of the ALS drug trial for AMX005.